Organización Nacional De Trasplantes-ko ikertzaileekin lankidetzan egindako argitalpenak (10)

2022

  1. Abdominal normothermic regional perfusion in controlled donation after circulatory determination of death liver transplantation: Outcomes and risk factors for graft loss

    American Journal of Transplantation, Vol. 22, Núm. 4, pp. 1169-1181

2021

  1. Epidemiological pattern, incidence, and outcomes of COVID-19 in liver transplant patients

    Journal of Hepatology, Vol. 74, Núm. 1, pp. 148-155

2019

  1. Normothermic regional perfusion vs. super-rapid recovery in controlled donation after circulatory death liver transplantation

    Journal of Hepatology, Vol. 70, Núm. 4, pp. 658-665

  2. Reply to: “Normothermic regional perfusion – What is the benefit?”

    Journal of Hepatology

  3. The UK DCD Risk Score: Still no consensus on futility in DCD liver transplantation

    Journal of Hepatology

2018

  1. Direct-acting antivirals are effective and safe in HCV/HIV-coinfected liver transplant recipients who experience recurrence of hepatitis C: A prospective nationwide cohort study

    American Journal of Transplantation, Vol. 18, Núm. 10, pp. 2513-2522

2016

  1. Erratum: Pegylated interferon plus ribavirin in HIV-infected patients with recurrent hepatitis C after liver transplantation: A prospective cohort study (Journal of Hepatology (2015) 62 (92-100))

    Journal of Hepatology

  2. Human immunodeficiency virus infection does not worsen prognosis of liver transplantation for hepatocellular carcinoma

    Hepatology, Vol. 63, Núm. 2, pp. 488-498

2015

  1. Activity and results of liver transplantation in Spain during 1984-2012. Analysis of the Spanish Liver Transplant Registry

    Medicina Clinica, Vol. 144, Núm. 8, pp. 337-347

  2. Pegylated interferon plus ribavirin in HIV-infected patients with recurrent hepatitis C after liver transplantation: A prospective cohort study

    Journal of Hepatology, Vol. 62, Núm. 1, pp. 92-100